Medical Journals

The Positive Allosteric Modulator Gs39783 Enhances Gaba(B) Receptor-mediated Inhibition of Cyclic Amp Formation in Rat Striatum in Vivo.

Authors:
  • Gjoni Tina
  • Desrayaud Sandrine
  • Imobersteg Stefan
  • Urwyler Stephan

From: Novartis Institutes for BioMedical Research, Neuroscience, Basel, Switzerland.

Journal of neurochemistry

  • Publish Date: Mar 2006
  • ISSN: 0022-3042
  • Volume: 96
  • Issue: 5
  • Pages: 1416-22
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gjoni Tina, Desrayaud Sandrine, Imobersteg Stefan, et al. The Positive Allosteric Modulator Gs39783 Enhances Gaba(B) Receptor-mediated Inhibition of Cyclic Amp Formation in Rat Striatum in Vivo.. J. Neurochem. Mar 2006;96:1416-22

Abstract

We studied the effects of the positive allosteric modulator GS39783 on GABA(B) receptors at a biochemical level in vivo. Changes in extracellular levels of cyclic AMP following GABA(B) receptor activation were monitored in the striatum of freely moving rats using microdialysis. Locally applied GABA(B) agonist R(-)-baclofen inhibited cyclic AMP formation stimulated by a water-soluble forskolin analogue in a concentration-dependent manner (EC50 7.3 microM, maximal inhibition 40%). The selective GABA(B) antagonist CGP56999 reversed R(-)-baclofen-induced cyclic AMP inhibition to control levels, but not higher. Orally applied GS39783 lacked effects on its own but, together with a threshold concentration of R(-)-baclofen (1 microM), significantly decreased cyclic AMP formation in a dose-dependent fashion. Effects of GS39783 were revoked with CGP56999, showing dependence on GABA(B) receptor activation and suggesting allosteric modulation as a mechanism of action in vivo. Administered with a maximally active dose of R(-)-baclofen, GS39783 failed to further inhibit cyclic AMP formation. The data obtained with CGP56999 and the lack of effect of GS39783 alone suggest that there is no detectable endogenous activation of GABA(B) receptors controlling cyclic AMP formation in rat striatum. To our knowledge, these results provide the first biochemical demonstration of in vivo activity of a G protein-coupled receptor-positive allosteric modulator.

Mesh Headings (Keywords): Animals, Baclofen, Corpus Striatum, Cyclic AMP, Cyclopentanes, Dose-Response Relationship, Drug, Drug Interactions, Forskolin, GABA Agonists, GABA Antagonists, Male, Microdialysis, Phosphinic Acids, Pyrimidines, Radioimmunoassay, Rats, Rats, Wistar, Receptors, GABA-A, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 16441514


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.